Latest Articles

In this interview, Avery Cunningham discusses the creation of STEM, LGBTQ & You, his experiences as a queer person in STEMM and the barriers that face LGBTQ+ individuals in the field.

In this interview, Alex Freeman, the founder of Octopus, discusses the progress made since the platform's launch and the ongoing challenges of establishing a new paradigm in academic publishing.

Scientists have taken a fresh approach to finding a way to target neuroblastoma, the most common solid tumor of infancy. Their novel gene target could offer hope for finding alternative treatments with fewer long-term side effects.

This article tells the story of Victoria Gray, the first patient to receive a CRISPR cell-based gene therapy for sickle cell disease (SCD). We explore the struggles of SCD, the mistreatment of minorities in medical settings and the implications of gene therapy accessibility.

The 28th International Symposium on Separation Sciences will be held in Messina, Italy on September 22–25, 2024, featuring oral and poster presentations as well as opportunities for the competitive to demonstrate their separation science prowess.

Trying to publish scientific research can be slow, demoralizing and put up barriers to progress. But what if there was another way, one that let authors take more control while making readers more informed about how their peers evaluate the study?

As research datasets become larger and harder to handle, maintaining data integrity standards is more important than ever. This article will feature interviews with experts and discuss the latest advances in the area.

In this article, we explore the importance of LEAF and how the choice of equipment – together with better habits – can significantly contribute to a greener and more sustainable future for laboratories.

In this opinion piece, Markus Gershater provides a comprehensive look into the current state and immense potential of artificial intelligence in reshaping the landscape of drug discovery.

In this article, we explore how mass spectrometry imaging technology is evolving into a high-resolution spatial biology toolset to transform drug discovery and development.